Bioray Biotech Co Stock

Bioray Biotech Co Debt

Debt of Bioray Biotech Co (7561.TWO) as of Aug 26, 2026.

Debt

0.00TWD

Last updated:

In 2026, Bioray Biotech Co's total debt was 0.00 TWD, a % change from the 85.78 M TWD total debt recorded in the previous year.

The Bioray Biotech Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
5.31 M TWD
Jan 1, 2019
63.38 M TWD
Jan 1, 2020
61.58 M TWD
Jan 1, 2021
53.43 M TWD
Jan 1, 2022
100.91 M TWD
Jan 1, 2023
69.79 M TWD
Jan 1, 2024
85.78 M TWD
Jan 1, 2025
0.00 TWD
The Bioray Biotech Co Debt history
YEARDebtYoY
0.00TWD-100.00%
85.78 MTWD+22.91%
69.79 MTWD-30.84%
100.91 MTWD+88.87%
53.43 MTWD-13.24%
61.58 MTWD-2.83%
63.38 MTWD+1,093.78%
5.31 MTWD—
0.00TWD—
Access this data via the Eulerpool API
Get Free API Key

Bioray Biotech Co Stock analysis

What does Bioray Biotech Co do? Bioray Biotech Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding Bioray Biotech Co's Debt Structure

Bioray Biotech Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Bioray Biotech Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Bioray Biotech Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Bioray Biotech Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Bioray Biotech Co stock

On Eulerpool you can find the complete historical development of Debt Bioray Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Debt's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Bioray Biotech Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Bioray Biotech Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bioray Biotech Co